These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31402445)

  • 21. 17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials.
    Almutairi AR; Aljohani HI; Al-Fadel NS
    Front Med (Lausanne); 2021; 8():764855. PubMed ID: 34926508
    [No Abstract]   [Full Text] [Related]  

  • 22. Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth.
    Ward A; Greenberg V; Valcarcel B; Boelig RC; Al-Kouatly HB; Berghella V
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100124. PubMed ID: 33345870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone therapy for prevention of recurrent spontaneous preterm birth in a minority patient population: a retrospective study.
    Mazza GR; Komatsu E; Ponzio M; Bai C; Cortessis VK; Sasso EB
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):252. PubMed ID: 38589796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental histology for targeted risk assessment of recurrent spontaneous preterm birth.
    Suresh S; Freedman A; Adams M; Hirsch E; Ernst LM
    Am J Obstet Gynecol; 2024 Apr; 230(4):452.e1-452.e11. PubMed ID: 37751829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.
    Price JT; Vwalika B; Freeman BL; Cole SR; Mulenga HB; Winston J; Mbewe FM; Chomba E; Mofenson LM; Rouse DJ; Goldenberg RL; Stringer JSA
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):81. PubMed ID: 30813934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing recurrent preterm birth with 125 mg of 17-alpha-hydroxyprogesterone caproate.
    Fukuda T; Kyozuka H; Murata T; Yasuda S; Yamaguchi A; Fujimori K
    J Obstet Gynaecol Res; 2021 Sep; 47(9):3119-3126. PubMed ID: 34219326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
    Sanchez-Ramos L; Kaunitz AM; Delke I
    Obstet Gynecol; 2005 Feb; 105(2):273-9. PubMed ID: 15684151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Regulation of the Nitric Oxide Pathway, 17-α Hydroxyprogesterone Caproate, and Recurrent Preterm Birth.
    Manuck TA; Smeester L; Martin EM; Tomlinson MS; Smith C; Varner MW; Fry RC
    Am J Perinatol; 2018 Jul; 35(8):721-728. PubMed ID: 29241278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.
    Alfirevic Z; Stampalija T; Roberts D; Jorgensen AL
    Cochrane Database Syst Rev; 2012 Apr; (4):CD008991. PubMed ID: 22513970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent Preterm Birth Reduction by 17-Hydroxyprogesterone Caproate in Dichorionic/Diamniotic Twin Gestation.
    Megli C; Combs CA; Venkataramanan R; Lemon L; Caritis SN
    Am J Perinatol; 2022 Aug; 39(11):1183-1188. PubMed ID: 33321529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention.
    Zhang S; Rascati KL
    Curr Med Res Opin; 2021 Sep; 37(9):1667-1675. PubMed ID: 34030550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity.
    Thinkhamrop J; Hofmeyr GJ; Adetoro O; Lumbiganon P; Ota E
    Cochrane Database Syst Rev; 2015 Jan; 1():CD002250. PubMed ID: 25621770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.
    Caritis SN; Feghali MN; Grobman WA; Rouse DJ;
    Semin Perinatol; 2016 Aug; 40(5):273-80. PubMed ID: 27105940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy duration with use of 17-α-hydroxyprogesterone caproate in a retrospective cohort at high risk of recurrent preterm birth.
    Massa K; Childress K; Vricella LK; Boerrigter A; Franklin BHK; Sauer M; Armbruster R; Tomlinson T
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100219. PubMed ID: 33345927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth.
    Alizadeh F; Mahmoudinia M; Mirteimoori M; Pourali L; Niroumand S
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):167. PubMed ID: 35232423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of omega-3 supplementation on pregnancy outcomes by smoking status.
    Kuper SG; Abramovici AR; Jauk VC; Harper LM; Biggio JR; Tita AT
    Am J Obstet Gynecol; 2017 Oct; 217(4):476.e1-476.e6. PubMed ID: 28549983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal administration of progesterone for preventing preterm birth.
    Dodd JM; Flenady V; Cincotta R; Crowther CA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004947. PubMed ID: 16437505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth.
    Edwards AM; Lowry SA; Mikovich S; Forinash AB; Babbar S
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100166. PubMed ID: 33345885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
    Awwad J; Usta IM; Ghazeeri G; Yacoub N; Succar J; Hayek S; Saasouh W; Nassar AH
    BJOG; 2015 Jan; 122(1):71-9. PubMed ID: 25163819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Obesity on the Rate of Recurrent Spontaneous Preterm Birth in Women Treated with 17-alpha Hydroxyprogesterone Caproate.
    Hauspurg A; Lemon LS; Serra AE; Sharma S; Venkataramanan R; Caritis SN
    Am J Perinatol; 2018 Jul; 35(9):809-814. PubMed ID: 29294501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.